WORK EXPERIENCE:
Takeda Pharmaceutical International Co. May 2015-Present
Global Regulatory Affairs Labeling
Creating and updating comparison chart matrix of approved USPI and EU-SmPC labels of oncology drugs
Assist in tracking of labeling updates for marketing applications in the countries such as Canada, Switzerland, Turkey and Columbia
Assist in the labeling research to support the NDA submission activities
Performed QC review of drafts country- specific labels to ensure consistency with Company Core Data Sheet (CCDS) for oncology drugs and escalate issues to Global Labeling Lead
Scheduling and attending cross-functional meetings with functional areas such as GRA Strategy, Pharmacovigilance, Clinical Pharmacology, Commercial and Legal
Documenting and distributing meeting minutes to the team members and tracking action items related to labeling.
Prepare the assessment on the current FDA OPDP enforcement trends related to advertising and promotional materials for oncology products
Organizing and maintaining labeling documentation on project specific SharePoint site for easy access by the project teams
Liberal Pharmaceuticals – Mumbai, India
Jr. Regulatory Affairs Associate Jan.2011- Jun.2012
Assisted in drafting marketing dossiers for antibiotics and anticancer drugs as per country specific CTD/ACTD format with appropriate regulations
Determined appropriate submission requirements and strategies to meet precise timelines
Prepared documents used for product dossier supplements, amendments and variations
Reviewed and evaluated quality documents and labeling material such as tray labels, cartons, package inserts, etc.
Khandelwal Labs Pvt. Ltd – Mumbai, India
Quality Assurance Intern Jun.2011-Jul.2011
Documented, maintained and archived batch manufacturing records, calibrated lab equipment and drafted product stability protocols as per GMP
Reviewed and updated various departmental SOP’s such as BMR, protocol deviation and implementation of CAPA
EDUCATION:
Northeastern University, Boston, MA (Expected) Mar.2016
Master of Science in Regulatory Affairs, Biologics and Medical Devices GPA:3.80/4.00
University of Mumbai, Mumbai, India Aug.2008-Jun.2012
Bachelor of Pharmacy
SKILLS AND CORE COMPETENCIES:
Regulatory Submissions: IND, NDA, ANDA, BLA, Case Report Form, Structure Product Labeling, Post Marketing Periodic and Annual Reports, well versed with eCTD backbone
Regulatory Compliance: CPP, cGMP, GLP, GCP, USPI, SmPC, Pharmacovigilance, Labeling Requirements, Advertising and Promotion and Clinical Trials
Computer Expertise: Proficient with publishing tools like, eCTDXpress,, Galaxy and Electronic document management systems (EDMS), Microsoft Office, Knowledge NET, SQL, Adobe Acrobat, Documentum, MS Share Point, MS Visio, Adobe Illustrator
Other: Team player, Strategy Planning and attention to detail
ACADEMIC PROJECTS:
Mock BLA/BLA Supplement filings and Labeling submissions:
Compiled a BLA using product information, preclinical and clinical data, labeling contents; and a supplement for updating previous label version including boxed warnings and extended use
Drafted a cover letter for BLA supplement and prepared the labeling changes for extending intended use of HPV vaccine
Mock IND/ NDA filing and submissions:
Drafted a cover letter along with FDA form 1571 requesting Pre-IND meeting to discuss clinical hold for Northera® (droxidopa) in the treatment of Neurogenic Orthostatic Hypotension to the FDA
Drafted a request letter for Orphan drug designation for Northera® (droxidopa) to the FDA
Drafted a NDA 505(b)(1) and 505(b) (2) submission for a drug product with a 356h form
CERTIFICATIONS:
Participated in “Protecting Human Research Participants” by National Institute of Health Office of Extramural Research, License 1521852.
The past, present and future of FDA human drug regulation certificate by FDA